M&A Deal Summary

Molecular Devices Acquires Applied Imaging

On September 7, 2006, Molecular Devices acquired healthcare services company Applied Imaging for 18M USD

Acquisition Highlights
  • This is Molecular Devices’ 1st transaction in the Healthcare Services sector.
  • This is Molecular Devices’ largest (disclosed) transaction.
  • This is Molecular Devices’ 2nd transaction in the United States.
  • This is Molecular Devices’ 2nd transaction in California.

M&A Deal Summary
Date 2006-09-07
Target Applied Imaging
Sector Healthcare Services
Buyer(s) Molecular Devices
Deal Type Add-on Acquisition
Deal Value 18M USD
Advisor(s) Aquilo Partners LP (Financial)

Target

Applied Imaging

San Jose, California, United States
Applied Imaging Corp., a supplier of automated imaging and image analysis systems.

Search 200,626 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Molecular Devices

Sunnyvale, California, United States
Category Company
Founded 1983
Sector Life Science
Employees631
DESCRIPTION

Molecular Devices LLC provides bioanalytical instruments, software, and assay kits for drug discovery & drug development, life science research, and bioassay/test development. Our global headquarters are located in the Silicon Valley area of Northern California. We also have a number of offices throughout the world.

DEAL STATS #
Overall 2 of 3
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 2 of 3
State (California) 2 of 2
Country (United States) 2 of 2
Year (2006) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2000-08-01 LJL Biosystems

Sunnyvale, California, United States

LJL Biosystems, Inc. is a provider of automated instrumentation systems for clinical, research and drug development applications.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-06 Cellesce

Cardiff, United Kingdom

Cellesce is a biotechnology company that specializes in contract development and manufacturing of large scale patient-derived organoids (PDOs) for diverse applications, including drug screening. Cellesce is based in Cardiff, United Kingdom.

Buy -
Mergr

Product

Company

Legal